COVID-19 Impact on Global Adoptive Cellular Immunotherapy Market Size, Status and Forecast 2020-2026

July 2020 | 153 pages | ID: CEAAA4DB2DC0EN
QYResearch

Abstracts

This report focuses on the global Adoptive Cellular Immunotherapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adoptive Cellular Immunotherapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Amgen Inc
• Autolus Therapeutics Plc
• Beijing Immunochina Medical Science & Technology Co Ltd
• Bellicum Pharmaceuticals Inc
• Bristol-Myers Squibb Co
• bluebird bio Inc
• CARsgen Therapeutics Ltd
• Celgene Corp
• Cell Medica Ltd
• Cellular Biomedicine Group Inc
• Celularity Inc
• Celyad SA
• Daiichi Sankyo Co Ltd
• Fosun Pharmaceutical AG
• Gilead Sciences Inc
• Guangzhou Anjie Biomedical Technology Co Ltd
• Hangzhou Converd Co Ltd
• Hebei Senlang Biotechnology Inc Ltd
• HRAIN Biotechnology Co Ltd
• Juno Therapeutics Inc
• Kite Pharma Inc
• Nanjing Legend Biotech Co Ltd
• NantKwest Inc
• Nkarta Inc
• Novartis AG
• Ono Pharmaceutical Co Ltd
• Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
• Sorrento Therapeutics Inc
• Takara Bio Inc

Market segment by Type, the product can be split into

• TIL
• LAK
• CAR-T
• TCR-T
• CIK
• NK
• DC
• Other

Market segment by Application, split into

• Hospital
• Cancer Hospital
• Centers for Disease Control and Prevention
• Rehabilitation Center
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Adoptive Cellular Immunotherapy status, future forecast, growth opportunity, key market and key players.
• To present the Adoptive Cellular Immunotherapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Adoptive Cellular Immunotherapy are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Adoptive Cellular Immunotherapy Revenue
1.4 Market Analysis by Type
  1.4.1 Global Adoptive Cellular Immunotherapy Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 TIL
  1.4.3 LAK
  1.4.4 CAR-T
  1.4.5 TCR-T
  1.4.6 CIK
  1.4.7 NK
  1.4.8 DC
  1.4.9 Other
1.5 Market by Application
  1.5.1 Global Adoptive Cellular Immunotherapy Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Cancer Hospital
  1.5.4 Centers for Disease Control and Prevention
  1.5.5 Rehabilitation Center
  1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Adoptive Cellular Immunotherapy Industry Impact
  1.6.1 How the Covid-19 is Affecting the Adoptive Cellular Immunotherapy Industry
    1.6.1.1 Adoptive Cellular Immunotherapy Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Adoptive Cellular Immunotherapy Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Adoptive Cellular Immunotherapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Adoptive Cellular Immunotherapy Market Perspective (2015-2026)
2.2 Adoptive Cellular Immunotherapy Growth Trends by Regions
  2.2.1 Adoptive Cellular Immunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Adoptive Cellular Immunotherapy Historic Market Share by Regions (2015-2020)
  2.2.3 Adoptive Cellular Immunotherapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Adoptive Cellular Immunotherapy Market Growth Strategy
  2.3.6 Primary Interviews with Key Adoptive Cellular Immunotherapy Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Adoptive Cellular Immunotherapy Players by Market Size
  3.1.1 Global Top Adoptive Cellular Immunotherapy Players by Revenue (2015-2020)
  3.1.2 Global Adoptive Cellular Immunotherapy Revenue Market Share by Players (2015-2020)
  3.1.3 Global Adoptive Cellular Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Adoptive Cellular Immunotherapy Market Concentration Ratio
  3.2.1 Global Adoptive Cellular Immunotherapy Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Adoptive Cellular Immunotherapy Revenue in 2019
3.3 Adoptive Cellular Immunotherapy Key Players Head office and Area Served
3.4 Key Players Adoptive Cellular Immunotherapy Product Solution and Service
3.5 Date of Enter into Adoptive Cellular Immunotherapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Adoptive Cellular Immunotherapy Historic Market Size by Type (2015-2020)
4.2 Global Adoptive Cellular Immunotherapy Forecasted Market Size by Type (2021-2026)

5 ADOPTIVE CELLULAR IMMUNOTHERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Adoptive Cellular Immunotherapy Market Size by Application (2015-2020)
5.2 Global Adoptive Cellular Immunotherapy Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Adoptive Cellular Immunotherapy Market Size (2015-2020)
6.2 Adoptive Cellular Immunotherapy Key Players in North America (2019-2020)
6.3 North America Adoptive Cellular Immunotherapy Market Size by Type (2015-2020)
6.4 North America Adoptive Cellular Immunotherapy Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Adoptive Cellular Immunotherapy Market Size (2015-2020)
7.2 Adoptive Cellular Immunotherapy Key Players in Europe (2019-2020)
7.3 Europe Adoptive Cellular Immunotherapy Market Size by Type (2015-2020)
7.4 Europe Adoptive Cellular Immunotherapy Market Size by Application (2015-2020)

8 CHINA

8.1 China Adoptive Cellular Immunotherapy Market Size (2015-2020)
8.2 Adoptive Cellular Immunotherapy Key Players in China (2019-2020)
8.3 China Adoptive Cellular Immunotherapy Market Size by Type (2015-2020)
8.4 China Adoptive Cellular Immunotherapy Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Adoptive Cellular Immunotherapy Market Size (2015-2020)
9.2 Adoptive Cellular Immunotherapy Key Players in Japan (2019-2020)
9.3 Japan Adoptive Cellular Immunotherapy Market Size by Type (2015-2020)
9.4 Japan Adoptive Cellular Immunotherapy Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Adoptive Cellular Immunotherapy Market Size (2015-2020)
10.2 Adoptive Cellular Immunotherapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Adoptive Cellular Immunotherapy Market Size by Type (2015-2020)
10.4 Southeast Asia Adoptive Cellular Immunotherapy Market Size by Application (2015-2020)

11 INDIA

11.1 India Adoptive Cellular Immunotherapy Market Size (2015-2020)
11.2 Adoptive Cellular Immunotherapy Key Players in India (2019-2020)
11.3 India Adoptive Cellular Immunotherapy Market Size by Type (2015-2020)
11.4 India Adoptive Cellular Immunotherapy Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Adoptive Cellular Immunotherapy Market Size (2015-2020)
12.2 Adoptive Cellular Immunotherapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Adoptive Cellular Immunotherapy Market Size by Type (2015-2020)
12.4 Central & South America Adoptive Cellular Immunotherapy Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Amgen Inc
  13.1.1 Amgen Inc Company Details
  13.1.2 Amgen Inc Business Overview and Its Total Revenue
  13.1.3 Amgen Inc Adoptive Cellular Immunotherapy Introduction
  13.1.4 Amgen Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020))
  13.1.5 Amgen Inc Recent Development
13.2 Autolus Therapeutics Plc
  13.2.1 Autolus Therapeutics Plc Company Details
  13.2.2 Autolus Therapeutics Plc Business Overview and Its Total Revenue
  13.2.3 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Introduction
  13.2.4 Autolus Therapeutics Plc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  13.2.5 Autolus Therapeutics Plc Recent Development
13.3 Beijing Immunochina Medical Science & Technology Co Ltd
  13.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details
  13.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview and Its Total Revenue
  13.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Introduction
  13.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  13.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
13.4 Bellicum Pharmaceuticals Inc
  13.4.1 Bellicum Pharmaceuticals Inc Company Details
  13.4.2 Bellicum Pharmaceuticals Inc Business Overview and Its Total Revenue
  13.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Introduction
  13.4.4 Bellicum Pharmaceuticals Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  13.4.5 Bellicum Pharmaceuticals Inc Recent Development
13.5 Bristol-Myers Squibb Co
  13.5.1 Bristol-Myers Squibb Co Company Details
  13.5.2 Bristol-Myers Squibb Co Business Overview and Its Total Revenue
  13.5.3 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Introduction
  13.5.4 Bristol-Myers Squibb Co Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  13.5.5 Bristol-Myers Squibb Co Recent Development
13.6 bluebird bio Inc
  13.6.1 bluebird bio Inc Company Details
  13.6.2 bluebird bio Inc Business Overview and Its Total Revenue
  13.6.3 bluebird bio Inc Adoptive Cellular Immunotherapy Introduction
  13.6.4 bluebird bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  13.6.5 bluebird bio Inc Recent Development
13.7 CARsgen Therapeutics Ltd
  13.7.1 CARsgen Therapeutics Ltd Company Details
  13.7.2 CARsgen Therapeutics Ltd Business Overview and Its Total Revenue
  13.7.3 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Introduction
  13.7.4 CARsgen Therapeutics Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  13.7.5 CARsgen Therapeutics Ltd Recent Development
13.8 Celgene Corp
  13.8.1 Celgene Corp Company Details
  13.8.2 Celgene Corp Business Overview and Its Total Revenue
  13.8.3 Celgene Corp Adoptive Cellular Immunotherapy Introduction
  13.8.4 Celgene Corp Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  13.8.5 Celgene Corp Recent Development
13.9 Cell Medica Ltd
  13.9.1 Cell Medica Ltd Company Details
  13.9.2 Cell Medica Ltd Business Overview and Its Total Revenue
  13.9.3 Cell Medica Ltd Adoptive Cellular Immunotherapy Introduction
  13.9.4 Cell Medica Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  13.9.5 Cell Medica Ltd Recent Development
13.10 Cellular Biomedicine Group Inc
  13.10.1 Cellular Biomedicine Group Inc Company Details
  13.10.2 Cellular Biomedicine Group Inc Business Overview and Its Total Revenue
  13.10.3 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Introduction
  13.10.4 Cellular Biomedicine Group Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  13.10.5 Cellular Biomedicine Group Inc Recent Development
13.11 Celularity Inc
  10.11.1 Celularity Inc Company Details
  10.11.2 Celularity Inc Business Overview and Its Total Revenue
  10.11.3 Celularity Inc Adoptive Cellular Immunotherapy Introduction
  10.11.4 Celularity Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.11.5 Celularity Inc Recent Development
13.12 Celyad SA
  10.12.1 Celyad SA Company Details
  10.12.2 Celyad SA Business Overview and Its Total Revenue
  10.12.3 Celyad SA Adoptive Cellular Immunotherapy Introduction
  10.12.4 Celyad SA Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.12.5 Celyad SA Recent Development
13.13 Daiichi Sankyo Co Ltd
  10.13.1 Daiichi Sankyo Co Ltd Company Details
  10.13.2 Daiichi Sankyo Co Ltd Business Overview and Its Total Revenue
  10.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Introduction
  10.13.4 Daiichi Sankyo Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.13.5 Daiichi Sankyo Co Ltd Recent Development
13.14 Fosun Pharmaceutical AG
  10.14.1 Fosun Pharmaceutical AG Company Details
  10.14.2 Fosun Pharmaceutical AG Business Overview and Its Total Revenue
  10.14.3 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Introduction
  10.14.4 Fosun Pharmaceutical AG Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.14.5 Fosun Pharmaceutical AG Recent Development
13.15 Gilead Sciences Inc
  10.15.1 Gilead Sciences Inc Company Details
  10.15.2 Gilead Sciences Inc Business Overview and Its Total Revenue
  10.15.3 Gilead Sciences Inc Adoptive Cellular Immunotherapy Introduction
  10.15.4 Gilead Sciences Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.15.5 Gilead Sciences Inc Recent Development
13.16 Guangzhou Anjie Biomedical Technology Co Ltd
  10.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Details
  10.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview and Its Total Revenue
  10.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Introduction
  10.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
13.17 Hangzhou Converd Co Ltd
  10.17.1 Hangzhou Converd Co Ltd Company Details
  10.17.2 Hangzhou Converd Co Ltd Business Overview and Its Total Revenue
  10.17.3 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Introduction
  10.17.4 Hangzhou Converd Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.17.5 Hangzhou Converd Co Ltd Recent Development
13.18 Hebei Senlang Biotechnology Inc Ltd
  10.18.1 Hebei Senlang Biotechnology Inc Ltd Company Details
  10.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview and Its Total Revenue
  10.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Introduction
  10.18.4 Hebei Senlang Biotechnology Inc Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Development
13.19 HRAIN Biotechnology Co Ltd
  10.19.1 HRAIN Biotechnology Co Ltd Company Details
  10.19.2 HRAIN Biotechnology Co Ltd Business Overview and Its Total Revenue
  10.19.3 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Introduction
  10.19.4 HRAIN Biotechnology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.19.5 HRAIN Biotechnology Co Ltd Recent Development
13.20 Juno Therapeutics Inc
  10.20.1 Juno Therapeutics Inc Company Details
  10.20.2 Juno Therapeutics Inc Business Overview and Its Total Revenue
  10.20.3 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Introduction
  10.20.4 Juno Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.20.5 Juno Therapeutics Inc Recent Development
13.21 Kite Pharma Inc
  10.21.1 Kite Pharma Inc Company Details
  10.21.2 Kite Pharma Inc Business Overview and Its Total Revenue
  10.21.3 Kite Pharma Inc Adoptive Cellular Immunotherapy Introduction
  10.21.4 Kite Pharma Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.21.5 Kite Pharma Inc Recent Development
13.22 Nanjing Legend Biotech Co Ltd
  10.22.1 Nanjing Legend Biotech Co Ltd Company Details
  10.22.2 Nanjing Legend Biotech Co Ltd Business Overview and Its Total Revenue
  10.22.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Introduction
  10.22.4 Nanjing Legend Biotech Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.22.5 Nanjing Legend Biotech Co Ltd Recent Development
13.23 NantKwest Inc
  10.23.1 NantKwest Inc Company Details
  10.23.2 NantKwest Inc Business Overview and Its Total Revenue
  10.23.3 NantKwest Inc Adoptive Cellular Immunotherapy Introduction
  10.23.4 NantKwest Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.23.5 NantKwest Inc Recent Development
13.24 Nkarta Inc
  10.24.1 Nkarta Inc Company Details
  10.24.2 Nkarta Inc Business Overview and Its Total Revenue
  10.24.3 Nkarta Inc Adoptive Cellular Immunotherapy Introduction
  10.24.4 Nkarta Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.24.5 Nkarta Inc Recent Development
13.25 Novartis AG
  10.25.1 Novartis AG Company Details
  10.25.2 Novartis AG Business Overview and Its Total Revenue
  10.25.3 Novartis AG Adoptive Cellular Immunotherapy Introduction
  10.25.4 Novartis AG Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.25.5 Novartis AG Recent Development
13.26 Ono Pharmaceutical Co Ltd
  10.26.1 Ono Pharmaceutical Co Ltd Company Details
  10.26.2 Ono Pharmaceutical Co Ltd Business Overview and Its Total Revenue
  10.26.3 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Introduction
  10.26.4 Ono Pharmaceutical Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.26.5 Ono Pharmaceutical Co Ltd Recent Development
13.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
  10.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
  10.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview and Its Total Revenue
  10.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Introduction
  10.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
13.28 Sorrento Therapeutics Inc
  10.28.1 Sorrento Therapeutics Inc Company Details
  10.28.2 Sorrento Therapeutics Inc Business Overview and Its Total Revenue
  10.28.3 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Introduction
  10.28.4 Sorrento Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.28.5 Sorrento Therapeutics Inc Recent Development
13.29 Takara Bio Inc
  10.29.1 Takara Bio Inc Company Details
  10.29.2 Takara Bio Inc Business Overview and Its Total Revenue
  10.29.3 Takara Bio Inc Adoptive Cellular Immunotherapy Introduction
  10.29.4 Takara Bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
  10.29.5 Takara Bio Inc Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Adoptive Cellular Immunotherapy Key Market Segments
Table 2. Key Players Covered: Ranking by Adoptive Cellular Immunotherapy Revenue
Table 3. Ranking of Global Top Adoptive Cellular Immunotherapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Adoptive Cellular Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of TIL
Table 6. Key Players of LAK
Table 7. Key Players of CAR-T
Table 8. Key Players of TCR-T
Table 9. Key Players of CIK
Table 10. Key Players of NK
Table 11. Key Players of DC
Table 12. Key Players of Other
Table 13. COVID-19 Impact Global Market: (Four Adoptive Cellular Immunotherapy Market Size Forecast Scenarios)
Table 14. Opportunities and Trends for Adoptive Cellular Immunotherapy Players in the COVID-19 Landscape
Table 15. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 16. Key Regions/Countries Measures against Covid-19 Impact
Table 17. Proposal for Adoptive Cellular Immunotherapy Players to Combat Covid-19 Impact
Table 18. Global Adoptive Cellular Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 19. Global Adoptive Cellular Immunotherapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 20. Global Adoptive Cellular Immunotherapy Market Size by Regions (2015-2020) (US$ Million)
Table 21. Global Adoptive Cellular Immunotherapy Market Share by Regions (2015-2020)
Table 22. Global Adoptive Cellular Immunotherapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 23. Global Adoptive Cellular Immunotherapy Market Share by Regions (2021-2026)
Table 24. Market Top Trends
Table 25. Key Drivers: Impact Analysis
Table 26. Key Challenges
Table 27. Adoptive Cellular Immunotherapy Market Growth Strategy
Table 28. Main Points Interviewed from Key Adoptive Cellular Immunotherapy Players
Table 29. Global Adoptive Cellular Immunotherapy Revenue by Players (2015-2020) (Million US$)
Table 30. Global Adoptive Cellular Immunotherapy Market Share by Players (2015-2020)
Table 31. Global Top Adoptive Cellular Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cellular Immunotherapy as of 2019)
Table 32. Global Adoptive Cellular Immunotherapy by Players Market Concentration Ratio (CR5 and HHI)
Table 33. Key Players Headquarters and Area Served
Table 34. Key Players Adoptive Cellular Immunotherapy Product Solution and Service
Table 35. Date of Enter into Adoptive Cellular Immunotherapy Market
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Adoptive Cellular Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 38. Global Adoptive Cellular Immunotherapy Market Size Share by Type (2015-2020)
Table 39. Global Adoptive Cellular Immunotherapy Revenue Market Share by Type (2021-2026)
Table 40. Global Adoptive Cellular Immunotherapy Market Size Share by Application (2015-2020)
Table 41. Global Adoptive Cellular Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 42. Global Adoptive Cellular Immunotherapy Market Size Share by Application (2021-2026)
Table 43. North America Key Players Adoptive Cellular Immunotherapy Revenue (2019-2020) (Million US$)
Table 44. North America Key Players Adoptive Cellular Immunotherapy Market Share (2019-2020)
Table 45. North America Adoptive Cellular Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 46. North America Adoptive Cellular Immunotherapy Market Share by Type (2015-2020)
Table 47. North America Adoptive Cellular Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 48. North America Adoptive Cellular Immunotherapy Market Share by Application (2015-2020)
Table 49. Europe Key Players Adoptive Cellular Immunotherapy Revenue (2019-2020) (Million US$)
Table 50. Europe Key Players Adoptive Cellular Immunotherapy Market Share (2019-2020)
Table 51. Europe Adoptive Cellular Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 52. Europe Adoptive Cellular Immunotherapy Market Share by Type (2015-2020)
Table 53. Europe Adoptive Cellular Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 54. Europe Adoptive Cellular Immunotherapy Market Share by Application (2015-2020)
Table 55. China Key Players Adoptive Cellular Immunotherapy Revenue (2019-2020) (Million US$)
Table 56. China Key Players Adoptive Cellular Immunotherapy Market Share (2019-2020)
Table 57. China Adoptive Cellular Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 58. China Adoptive Cellular Immunotherapy Market Share by Type (2015-2020)
Table 59. China Adoptive Cellular Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 60. China Adoptive Cellular Immunotherapy Market Share by Application (2015-2020)
Table 61. Japan Key Players Adoptive Cellular Immunotherapy Revenue (2019-2020) (Million US$)
Table 62. Japan Key Players Adoptive Cellular Immunotherapy Market Share (2019-2020)
Table 63. Japan Adoptive Cellular Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 64. Japan Adoptive Cellular Immunotherapy Market Share by Type (2015-2020)
Table 65. Japan Adoptive Cellular Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 66. Japan Adoptive Cellular Immunotherapy Market Share by Application (2015-2020)
Table 67. Southeast Asia Key Players Adoptive Cellular Immunotherapy Revenue (2019-2020) (Million US$)
Table 68. Southeast Asia Key Players Adoptive Cellular Immunotherapy Market Share (2019-2020)
Table 69. Southeast Asia Adoptive Cellular Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 70. Southeast Asia Adoptive Cellular Immunotherapy Market Share by Type (2015-2020)
Table 71. Southeast Asia Adoptive Cellular Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 72. Southeast Asia Adoptive Cellular Immunotherapy Market Share by Application (2015-2020)
Table 73. India Key Players Adoptive Cellular Immunotherapy Revenue (2019-2020) (Million US$)
Table 74. India Key Players Adoptive Cellular Immunotherapy Market Share (2019-2020)
Table 75. India Adoptive Cellular Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 76. India Adoptive Cellular Immunotherapy Market Share by Type (2015-2020)
Table 77. India Adoptive Cellular Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 78. India Adoptive Cellular Immunotherapy Market Share by Application (2015-2020)
Table 79. Central & South America Key Players Adoptive Cellular Immunotherapy Revenue (2019-2020) (Million US$)
Table 80. Central & South America Key Players Adoptive Cellular Immunotherapy Market Share (2019-2020)
Table 81. Central & South America Adoptive Cellular Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 82. Central & South America Adoptive Cellular Immunotherapy Market Share by Type (2015-2020)
Table 83. Central & South America Adoptive Cellular Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 84. Central & South America Adoptive Cellular Immunotherapy Market Share by Application (2015-2020)
Table 85. Amgen Inc Company Details
Table 86. Amgen Inc Business Overview
Table 87. Amgen Inc Product
Table 88. Amgen Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 89. Amgen Inc Recent Development
Table 90. Autolus Therapeutics Plc Company Details
Table 91. Autolus Therapeutics Plc Business Overview
Table 92. Autolus Therapeutics Plc Product
Table 93. Autolus Therapeutics Plc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 94. Autolus Therapeutics Plc Recent Development
Table 95. Beijing Immunochina Medical Science & Technology Co Ltd Company Details
Table 96. Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
Table 97. Beijing Immunochina Medical Science & Technology Co Ltd Product
Table 98. Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 99. Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
Table 100. Bellicum Pharmaceuticals Inc Company Details
Table 101. Bellicum Pharmaceuticals Inc Business Overview
Table 102. Bellicum Pharmaceuticals Inc Product
Table 103. Bellicum Pharmaceuticals Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 104. Bellicum Pharmaceuticals Inc Recent Development
Table 105. Bristol-Myers Squibb Co Company Details
Table 106. Bristol-Myers Squibb Co Business Overview
Table 107. Bristol-Myers Squibb Co Product
Table 108. Bristol-Myers Squibb Co Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 109. Bristol-Myers Squibb Co Recent Development
Table 110. bluebird bio Inc Company Details
Table 111. bluebird bio Inc Business Overview
Table 112. bluebird bio Inc Product
Table 113. bluebird bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 114. bluebird bio Inc Recent Development
Table 115. CARsgen Therapeutics Ltd Company Details
Table 116. CARsgen Therapeutics Ltd Business Overview
Table 117. CARsgen Therapeutics Ltd Product
Table 118. CARsgen Therapeutics Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 119. CARsgen Therapeutics Ltd Recent Development
Table 120. Celgene Corp Business Overview
Table 121. Celgene Corp Product
Table 122. Celgene Corp Company Details
Table 123. Celgene Corp Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 124. Celgene Corp Recent Development
Table 125. Cell Medica Ltd Company Details
Table 126. Cell Medica Ltd Business Overview
Table 127. Cell Medica Ltd Product
Table 128. Cell Medica Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 129. Cell Medica Ltd Recent Development
Table 130. Cellular Biomedicine Group Inc Company Details
Table 131. Cellular Biomedicine Group Inc Business Overview
Table 132. Cellular Biomedicine Group Inc Product
Table 133. Cellular Biomedicine Group Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 134. Cellular Biomedicine Group Inc Recent Development
Table 135. Celularity Inc Company Details
Table 136. Celularity Inc Business Overview
Table 137. Celularity Inc Product
Table 138. Celularity Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 139. Celularity Inc Recent Development
Table 140. Celyad SA Company Details
Table 141. Celyad SA Business Overview
Table 142. Celyad SA Product
Table 143. Celyad SA Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 144. Celyad SA Recent Development
Table 145. Daiichi Sankyo Co Ltd Company Details
Table 146. Daiichi Sankyo Co Ltd Business Overview
Table 147. Daiichi Sankyo Co Ltd Product
Table 148. Daiichi Sankyo Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 149. Daiichi Sankyo Co Ltd Recent Development
Table 150. Fosun Pharmaceutical AG Company Details
Table 151. Fosun Pharmaceutical AG Business Overview
Table 152. Fosun Pharmaceutical AG Product
Table 153. Fosun Pharmaceutical AG Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 154. Fosun Pharmaceutical AG Recent Development
Table 155. Gilead Sciences Inc Company Details
Table 156. Gilead Sciences Inc Business Overview
Table 157. Gilead Sciences Inc Product
Table 158. Gilead Sciences Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 159. Gilead Sciences Inc Recent Development
Table 160. Guangzhou Anjie Biomedical Technology Co Ltd Company Details
Table 161. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
Table 162. Guangzhou Anjie Biomedical Technology Co Ltd Product
Table 163. Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 164. Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
Table 165. Hangzhou Converd Co Ltd Company Details
Table 166. Hangzhou Converd Co Ltd Business Overview
Table 167. Hangzhou Converd Co Ltd Product
Table 168. Hangzhou Converd Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 169. Hangzhou Converd Co Ltd Recent Development
Table 170. Hebei Senlang Biotechnology Inc Ltd Company Details
Table 171. Hebei Senlang Biotechnology Inc Ltd Business Overview
Table 172. Hebei Senlang Biotechnology Inc Ltd Product
Table 173. Hebei Senlang Biotechnology Inc Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 174. Hebei Senlang Biotechnology Inc Ltd Recent Development
Table 175. HRAIN Biotechnology Co Ltd Company Details
Table 176. HRAIN Biotechnology Co Ltd Business Overview
Table 177. HRAIN Biotechnology Co Ltd Product
Table 178. HRAIN Biotechnology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 179. HRAIN Biotechnology Co Ltd Recent Development
Table 180. Juno Therapeutics Inc Company Details
Table 181. Juno Therapeutics Inc Business Overview
Table 182. Juno Therapeutics Inc Product
Table 183. Juno Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 184. Juno Therapeutics Inc Recent Development
Table 185. Kite Pharma Inc Company Details
Table 186. Kite Pharma Inc Business Overview
Table 187. Kite Pharma Inc Product
Table 188. Kite Pharma Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 189. Kite Pharma Inc Recent Development
Table 190. Nanjing Legend Biotech Co Ltd Company Details
Table 191. Nanjing Legend Biotech Co Ltd Business Overview
Table 192. Nanjing Legend Biotech Co Ltd Product
Table 193. Nanjing Legend Biotech Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 194. Nanjing Legend Biotech Co Ltd Recent Development
Table 195. NantKwest Inc Company Details
Table 196. NantKwest Inc Business Overview
Table 197. NantKwest Inc Product
Table 198. NantKwest Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 199. NantKwest Inc Recent Development
Table 200. Nkarta Inc Company Details
Table 201. Nkarta Inc Business Overview
Table 202. Nkarta Inc Product
Table 203. Nkarta Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 204. Nkarta Inc Recent Development
Table 205. Novartis AG Company Details
Table 206. Novartis AG Business Overview
Table 207. Novartis AG Product
Table 208. Novartis AG Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 209. Novartis AG Recent Development
Table 210. Ono Pharmaceutical Co Ltd Company Details
Table 211. Ono Pharmaceutical Co Ltd Business Overview
Table 212. Ono Pharmaceutical Co Ltd Product
Table 213. Ono Pharmaceutical Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 214. Ono Pharmaceutical Co Ltd Recent Development
Table 215. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
Table 216. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
Table 217. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Product
Table 218. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 219. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
Table 220. Sorrento Therapeutics Inc Company Details
Table 221. Sorrento Therapeutics Inc Business Overview
Table 222. Sorrento Therapeutics Inc Product
Table 223. Sorrento Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 224. Sorrento Therapeutics Inc Recent Development
Table 225. Takara Bio Inc Company Details
Table 226. Takara Bio Inc Business Overview
Table 227. Takara Bio Inc Product
Table 228. Takara Bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 229. Takara Bio Inc Recent Development
Table 230. Research Programs/Design for This Report
Table 231. Key Data Information from Secondary Sources
Table 232. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Adoptive Cellular Immunotherapy Market Share by Type: 2020 VS 2026
Figure 2. TIL Features
Figure 3. LAK Features
Figure 4. CAR-T Features
Figure 5. TCR-T Features
Figure 6. CIK Features
Figure 7. NK Features
Figure 8. DC Features
Figure 9. Other Features
Figure 10. Global Adoptive Cellular Immunotherapy Market Share by Application: 2020 VS 2026
Figure 11. Hospital Case Studies
Figure 12. Cancer Hospital Case Studies
Figure 13. Centers for Disease Control and Prevention Case Studies
Figure 14. Rehabilitation Center Case Studies
Figure 15. Other Case Studies
Figure 16. Adoptive Cellular Immunotherapy Report Years Considered
Figure 17. Global Adoptive Cellular Immunotherapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 18. Global Adoptive Cellular Immunotherapy Market Share by Regions: 2020 VS 2026
Figure 19. Global Adoptive Cellular Immunotherapy Market Share by Regions (2021-2026)
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Adoptive Cellular Immunotherapy Market Share by Players in 2019
Figure 22. Global Top Adoptive Cellular Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cellular Immunotherapy as of 2019
Figure 23. The Top 10 and 5 Players Market Share by Adoptive Cellular Immunotherapy Revenue in 2019
Figure 24. North America Adoptive Cellular Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Europe Adoptive Cellular Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. China Adoptive Cellular Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Japan Adoptive Cellular Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Southeast Asia Adoptive Cellular Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. India Adoptive Cellular Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Central & South America Adoptive Cellular Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Amgen Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Amgen Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 33. Autolus Therapeutics Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Autolus Therapeutics Plc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 35. Beijing Immunochina Medical Science & Technology Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Beijing Immunochina Medical Science & Technology Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 37. Bellicum Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Bellicum Pharmaceuticals Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 39. Bristol-Myers Squibb Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Bristol-Myers Squibb Co Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 41. bluebird bio Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. bluebird bio Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 43. CARsgen Therapeutics Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. CARsgen Therapeutics Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 45. Celgene Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Celgene Corp Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 47. Cell Medica Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Cell Medica Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 49. Cellular Biomedicine Group Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Cellular Biomedicine Group Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 51. Celularity Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Celularity Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 53. Celyad SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Celyad SA Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 55. Daiichi Sankyo Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Daiichi Sankyo Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 57. Fosun Pharmaceutical AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Fosun Pharmaceutical AG Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 59. Gilead Sciences Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Gilead Sciences Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 61. Guangzhou Anjie Biomedical Technology Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Guangzhou Anjie Biomedical Technology Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 63. Hangzhou Converd Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Hangzhou Converd Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 65. Hebei Senlang Biotechnology Inc Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Hebei Senlang Biotechnology Inc Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 67. HRAIN Biotechnology Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. HRAIN Biotechnology Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 69. Juno Therapeutics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Juno Therapeutics Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2015-2020)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed